Technical Analysis for BIB - ProShares Ultra Nasdaq Biotechnology

Grade Last Price % Change Price Change
grade D 53.21 -3.73% -2.06
BIB closed down 3.73 percent on Thursday, February 21, 2019, on 30 percent of normal volume.
4 Watchers
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Up Down
See historical BIB trend table...

Date Alert Name Type % Chg
Feb 21 Fell Below 20 DMA Bearish 0.00%
Feb 21 MACD Bearish Signal Line Cross Bearish 0.00%
Feb 21 Stochastic Sell Signal Bearish 0.00%
Feb 21 Overbought Stochastic Strength 0.00%
Feb 21 Down 3 Days in a Row Weakness 0.00%
Feb 20 Slingshot Bullish Bullish Swing Setup -3.73%
Feb 20 Overbought Stochastic Strength -3.73%
Feb 19 Volume Surge Other -4.33%
Feb 19 Upper Bollinger Band Walk Strength -4.33%
Feb 19 Overbought Stochastic Strength -4.33%

Older signals for BIB ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Read My Charts!
Configure default chart indicators
Basic chart:

Profile
The investment seeks daily investment results that correspond to two times (2x) the daily performance of the Nasdaq Biotechnology Index®. The fund invests in securities and derivatives that ProShare Advisors believes, in combination, should have similar daily return characteristics as two times (2x) the daily return of the index. The index is a modified capitalization weighted index that includes securities of NASDAQ listed companies that are classified as either biotechnology or pharmaceutical according to the Industry Classification Benchmark ("ICB") which also meet other eligibility criteria determined by NASDAQ. The fund is non-diversified.
Exchange Traded Funds Stock Market Index Biotechnology Nasdaq Economy Of New York City Nasdaq 100 Nasdaq Biotechnology Total Return Index
Is BIB a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
Feb 21 U.S. healthcare spending to rise 5.5% per annum over next decade
Jan 23 Jefferies bearish on biotechs, sees 6% near-term downside
Jan 15 FDA Commish touts advances/successes
Jan 14 Rep. Cummings opens investigation into drug prices
Jan 4 Citi sees equities returning 14% in 2019
Jan 4 Biotechs lead broad market advance, XBI up 5%
Jan 2 Drug makers OK with price inclusion in TV ads if done fairly
Jan 2 U.S. government shutdown hampers FDA
Dec 13 Senate Dems introduce bill to block "excessive" increases in drug prices
Dec 11 Trump Foreshadows a Bleak Outlook for Biotech (IBB, BIB)
See more BIB news...
Indicators
Indicator Value
52 Week High 70.82
52 Week Low 36.05
Average Volume 201,271
200-Day Moving Average 57.1457
50-Day Moving Average 49.9287
20-Day Moving Average 53.597
10-Day Moving Average 53.847
Average True Range 1.7934
ADX 14.0
+DI 26.0421
-DI 26.1616
Chandelier Exit (Long, 3 ATRs ) 51.1898
Chandelier Exit (Short, 3 ATRs ) 55.8802
Upper Bollinger Band 56.2249
Lower Bollinger Band 50.9691
Percent B (%b) 0.43
BandWidth 9.806146
MACD Line 1.0225
MACD Signal Line 1.1092
MACD Histogram -0.0867
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 56.51
Resistance 3 (R3) 56.80 55.98 55.96
Resistance 2 (R2) 55.98 55.14 55.84 55.78
Resistance 1 (R1) 54.60 54.62 54.19 54.31 55.59
Pivot Point 53.78 53.78 53.58 53.64 53.78
Support 1 (S1) 52.40 52.94 51.99 52.11 50.83
Support 2 (S2) 51.58 52.42 51.44 50.64
Support 3 (S3) 50.20 51.58 50.46
Support 4 (S4) 49.91